Deal Library / Pharma BD Deal Intelligence

Pharma Deals of 2008

The Pharma Closeout tracks 25 deals, $49.2B in disclosed deal value, 25 with a post-close Outcome Score for the year 2008.

Median Critic Score: 75  ·  Median Outcome Score: 36

Best outcome: ViroPharma Incorporated / Lev Pharmaceuticals, Inc. (88)  ·  Weakest outcome: Pfizer Inc. / Medivation, Inc. (9)

All 25 deals

• ViroPharma Incorporated / Lev Pharmaceuticals, Inc. — 2008 · $443M · Worked — the deal delivered on its rationale.
• Roche Holding AG / Ventana Medical Systems Inc. — 2008 · $3.4B · Worked — the deal delivered on its rationale.
• Shire plc / Jerini AG — 2008 · $521M · Worked — the deal delivered on its rationale.
• Alkermes, Inc. / Cephalon, Inc. (Vivitrol rights) — 2008 · $27M · Worked — the deal delivered on its rationale.
• Sanofi-Aventis / Symbion Consumer (Primary Health Care) — 2008 · $544M · Largely worked — most objectives met.
• Takeda Pharmaceutical Company Limited / Millennium Pharmaceuticals, Inc. — 2008 · $8.8B · Largely worked — most objectives met.
• Fresenius SE / Fresenius Kabi / APP Pharmaceuticals, Inc. — 2008 · $3.7B · Largely worked — most objectives met.
• Eli Lilly and Company / ImClone Systems Incorporated — 2008 · $6.5B · Largely worked — most objectives met.
• Teva Pharmaceutical Industries Ltd. / Barr Pharmaceuticals — 2008 · $7.5B · Mixed — partial payoff, real shortfalls.
• Invitrogen Corporation / Applied Biosystems Inc. — 2008 · $6.7B · Mixed — partial payoff, real shortfalls.
• Stiefel Laboratories, Inc. / Barrier Therapeutics, Inc. — 2008 · $148M · Underwhelmed — fell short of the thesis.
• Hologic, Inc. / Third Wave Technologies, Inc. — 2008 · $580M · Underwhelmed — fell short of the thesis.
• Sanofi-Aventis (Sanofi Pasteur) / Acambis plc — 2008 · $548M · Underwhelmed — fell short of the thesis.
• Bayer HealthCare AG / Direvo Biotech AG — 2008 · $300M · Underwhelmed — fell short of the thesis.
• Roche Holding AG / Piramed Pharma — 2008 · $175M · Did not work — the deal failed to deliver.
• King Pharmaceuticals, Inc. / Alpharma Inc. — 2008 · $1.6B · Did not work — the deal failed to deliver.
• Bristol-Myers Squibb Company / Kosan Biosciences Incorporated — 2008 · $190M · Did not work — the deal failed to deliver.
• GlaxoSmithKline plc / Genelabs Technologies, Inc. — 2008 · $57M · Did not work — the deal failed to deliver.
• Novartis AG / Speedel Holding AG — 2008 · $880M · Did not work — the deal failed to deliver.
• Daiichi Sankyo Company, Limited / Ranbaxy Laboratories Limited — 2008 · $4.6B · Did not work — the deal failed to deliver.
• Bristol-Myers Squibb Company / Exelixis, Inc. — 2008 · $240M · Did not work — the deal failed to deliver.
• Roche Holding AG / Mirus Bio Corporation — 2008 · $125M · Did not work — the deal failed to deliver.
• Pfizer Inc. / Medivation, Inc. — 2008 · $725M · Did not work — the deal failed to deliver.
• Pfizer Inc. / Encysive Pharmaceuticals Inc. — 2008 · $195M · Did not work — the deal failed to deliver.
• GlaxoSmithKline plc / Sirtris Pharmaceuticals, Inc. — 2008 · $720M · Did not work — the deal failed to deliver.

← Deal Library  ·  Interactive search  ·  How we score deals